Article Details
Retrieved on: 2021-08-23 06:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
ZURICH (Reuters) - Lonza is investing in new drug product manufacturing capacity at its site in Guangzhou, China, the Swiss company said on Monday.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here